DESTINEE WOODS: Open Payments
NPI 1821746140 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 18 payments from 10 companies in 2025. Trend: 2023 $2,618 · 2024 $1,762 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $119 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $91 |
| Axsome Therapeutics, Inc. | 3 | $72 |
| ABBVIE INC. | 2 | $51 |
| Corium, LLC | 2 | $29 |
| Lundbeck LLC | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: AUSTEDO XR, CAPLYTA, Auvelity, VRAYLAR, Azstarys, REXULTI, FANAPT, Jornay PM.
Industry payments across MS — which companies pay providers there.
